Pharma Sector Ready for A Rally !!!!!!..

 Pharma Sector Ready for A Rally !!!!!!..

CNX Pharma

Sun Pharmaceutical Industries Ltd.

 

Divi's Laboratories Ltd.

 Dr. Reddy's Laboratories Ltd

Also other heavy weightage Pharma Companies like

Lupin Ltd.
Cipla Ltd.
Aurobindo Pharma Ltd.
Glenmark Pharmaceuticals Ltd.
Cadila Healthcare Ltd.
Glaxosmithkline Pharmaceuticals Ltd.

Near Support made bullish Candlestick Pattern which shows some big hands interested in Pharma Sector...


Disclaimer: This is just for Study purpose.Refer your Financial planner beforw making any investement decision.










Regards,



Happy Trading...


Devang Varma.

   

TITAN SHORT TERM TECHNICAL VIEW

NSE CODE- TITAN 

BSE CODE- 500114 TITAN INDUSTRIES

Stock has been in a strong uptrend since 2009 till September 2014.Due to recent fall in bullion market,stock prices are under pressure and showed a decent correction on daily charts.It may touch 365-360 levels which is a strong support area for short term trend which can bounce price around 15-20% in coming months.

Can 400+ in coming 3-4 months...

SL is close below 360..

HAPPY TRADING....

Disclaimer : The Above view is purely for educational purpose. Nothing contained herein is a solicitation to trade or a recommendation of a specific trade. By reading this publication you agree to make no trade relying in whole or in part on the comments of the writers.

CESC UPDATE 

NSE CODE= CESC LTD.
BSE CODE= 500084 CESC LTD.


STOCK TRADING AT IT'S  LONG TERM TREND LINE SUPPORT..
EVERY BOUNCE FROM THE TREND LINE MADE STOCK RALLY AROUND 45-50% WITHIN 3 MONTHS TIME AND NOW WITH SAME PRICE PATTERN(BULLISH CANDLESTICK REVERSAL PATTERN WITH HIGH VOLUMES) AND ALSO MOMENTUM INDICATORS(RSI) CONFIRMING THE SAME..

SO ITS TIME FOR HISTORY TO REPEAT ITSELF....


CAN SEE  900++ IN COMING 3-5 MONTHS
SL CLOSE BELOW 658 



HAPPY TRADING

Disclaimer  :The Above view is purely for educational purpose. Nothing contained herein is a solicitation to trade or a recommendation of a specific trade. By reading this publication you agree to make no trade relying in whole or in part on the comments of the writers.